These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1717173)

  • 21. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Sicilian Gambit: reasons for maintaining the present antiarrhythmic drug classification.
    Harrison DC
    Cardiovasc Res; 1992 Jun; 26(6):566-7. PubMed ID: 1451134
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J; Zhou J; Patel C; Yan GX
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present status in and prospects for anti-arrhythmic drug therapy: Theoretical selection of therapeutic drugs for arrhythmia by Sicilian Gambit and the practice guidelines].
    Kato T
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):246-52. PubMed ID: 16536074
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sicilian gambit; a new strategy for antiarrhythmic therapy].
    Katoh T
    J Nippon Med Sch; 2002 Feb; 69(1):7-12. PubMed ID: 11847503
    [No Abstract]   [Full Text] [Related]  

  • 27. The Sicilian Gambit: a response to Drs Colatsky and Harrison.
    Rosen MR; Janse MJ; Schwartz PJ
    Cardiovasc Res; 1992 Jun; 26(6):568-70. PubMed ID: 1451135
    [No Abstract]   [Full Text] [Related]  

  • 28. [Class-I antiarrhythmic drugs].
    Kuga K; Sugishita Y
    Nihon Rinsho; 1996 Aug; 54(8):2110-6. PubMed ID: 8810785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The search for novel antiarrhythmic strategies. Sicilian Gambit.
    Jpn Circ J; 1998 Sep; 62(9):633-48. PubMed ID: 9766701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination.
    Grant AO
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):432-44. PubMed ID: 9058847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["Sicilian gambit": basic principles and strategies of anti-arrhythmia therapy. Satellite symposium of the 15th Congress of the European Society for Cardiology, Barcelona, 30 August 1992].
    Internist (Berl); 1993 Jan; 34(1 Suppl [sizilian]):1-20. PubMed ID: 8626211
    [No Abstract]   [Full Text] [Related]  

  • 32. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guidelines for antiarrhythmic therapy].
    Hagiwara Y; Ogawa S
    Nihon Rinsho; 2002 Jul; 60(7):1278-85. PubMed ID: 12136604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical potential of emerging antiarrhythmic agents.
    Capucci A; Aschieri D; Villani GQ; Piepoli MF
    Drugs R D; 1999 Apr; 1(4):279-90. PubMed ID: 10566046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.
    Thomas D; Christ T; Fabritz L; Goette A; Hammwöhner M; Heijman J; Kockskämper J; Linz D; Odening KE; Schweizer PA; Wakili R; Voigt N
    Clin Res Cardiol; 2019 Jun; 108(6):577-599. PubMed ID: 30306295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New directions in the development of antiarrhythmic drugs.
    Miura DS; Rosen MR
    J Clin Pharmacol; 1984 Jul; 24(7):333-41. PubMed ID: 6090508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Sicilian Gambit revisited--theory and practice.
    Schwartz PJ; Zaza A
    Eur Heart J; 1992 Nov; 13 Suppl F():23-9. PubMed ID: 1478220
    [No Abstract]   [Full Text] [Related]  

  • 39. Putting the Sicilian Gambit to the test.
    Janse MJ
    Eur Heart J; 1992 Nov; 13 Suppl F():30-7. PubMed ID: 1335870
    [No Abstract]   [Full Text] [Related]  

  • 40. Arrhythmogenic actions of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am J Cardiol; 1987 Apr; 59(11):10E-18E. PubMed ID: 2437786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.